Table 2. Correlations between CIMT and other parameters.

	All participants (n=84)		Control Group (n=42)		Patient group with prediabetes (n=42)
	r	p	r	p	r	p
Endocan (ng/L) *	0.206	0.060	0.340	0.028	0.104	0.514
Age (Year)	0.363	0.001	0.490	0.001	0.215	0.172
BMI (kg/m2)	-0.015	0.895	-0.009	0.956	0.034	0.833
FPI ((µU/mL)	0.180	0.104	0.360	0.021	0.020	0.900
FPG (mg/dL)	0.195	0.075	0.212	0.178	0.119	0.454
2-h PG (OGTT)	0.166	0.131	0.080	0.485	0.164	0.300
HOMA-IR	0.180	0.102	0.379	0.013	0.004	0.982
HbA1c (%)	0.242	0.080	0.349	0.143	0.199	0.260
CRP (mg/L)	0.077	0.520	0.063	0.694	0.065	0.730
Total-C (mg/dL)	-0.015	0.895	-0.076	0.632	-0.015	0.927
LDL-C (mg/dL)	-0.031	0.781	-0.093	0.557	-0.192	0.223
HDL-C (mg/dL)	-0.111	0.313	0.032	0.839	0.227	0.149
TG (mg/dL)*	0.257	0.018	0.306	0.030	0.342	0.027

BMI: body mass index; FPI: fasting plasma insulin; FPG: fasting plasma glucose; PG: plasma glucose; OGTT: oral glucose tolerance test; HOMA-IR: homeostasis model assessment-estimated insulin resistance; HbA1c: glycated hemoglobin; CRP: C-reactive protein; Total-C: Total cholesterol; LDL-C: low density lipoprotein-cholesterol; HDL-C: high density lipoprotein-cholesterol; TG: triglycerides; CIMT: carotid intima-media thickness.*Spearman correlation test, others: Pearson correlation test.